慢性閉塞性肺疾患(COPD)治療薬の世界市場2016-2020...市場調査レポートについてご紹介

【英文タイトル】Global Chronic Obstructive Pulmonary Disease Drugs Market 2016-2020

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼
慢性閉塞性肺疾患(COPD)治療薬の世界市場2016-2020 (Code:IRTNTR9968)

【レポートの概要(一部)】

About Chronic Obstructive Pulmonary Disease (COPD)
COPD is a chronic disease condition with a combination of symptoms of both chronic bronchitis and emphysema. Chronic bronchitis results in inflammation in the bronchioles, which results in increased mucus production. The condition is usually associated with a long-term cough with mucus. Emphysema results in the destruction of the walls of the alveoli, resulting in difficulty in breathing.

Technavio’s analysts forecast the global chronic obstructive pulmonary disease (COPD) drugs market to grow at a CAGR of 4.85% during the period 2016-2020.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global chronic obstructive pulmonary disease (COPD) drugs market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded, generic, and off-label drugs used to treat COPD.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• AstraZeneca
• Boehringer Ingelheim
• GSK
• Merck
• Novartis
• Teva

[Other prominent vendors]
• Ache Laboratorios Farmaceuticos
• Almirall
• Aquinox Pharmaceuticals
• Ario Pharma
• Asmacure
• Astellas Pharma
• BioMarck Pharmaceuticals
• Chiesi Farmaceutici
• Cytokinetics
• F. Hoffmann-La Roche
• Gilead Sciences
• Innoviva
• Invion
• MediciNova
• Mereo BioPharma
• Mylan
• Orion Corporation
• Palobiofarma
• Pearl Therapeutics
• Pharmaxis
• Prosonix
• Pulmagen Therapeutics
• RespiVert
• SolAeroMed
• Sunovion Pharmaceuticals
• Theravance Biopharma
• Theron Pharmaceuticals
• Verona Pharma
• Xention
• Yungjin Pharm
• ZAI Lab

[Market driver]
• Uptake of LABA/LAMA combination therapies
• For a full, detailed list, view our report

[Market challenge]
• Negligence toward use of controller medications
• For a full, detailed list, view our report

[Market trend]
• Increased adoption of e-cigarettes and smoking cessation products
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

※You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

.....

【日本語概要(※自動翻訳出力)】

※以下は、Microsoft社の翻訳システムを使用した自動翻訳結果です。レイアウト崩れと不自然な日本語表現が多く表示されます。

。。。(後略)

【レポートの目次(一部)】

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights
• Breakthrough in COPD research
• COPD: An overview

PART 05: Pipeline analysis

PART 06: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 07: Key buying criteria for COPD drugs

PART 08: Market segmentation by drug class
• Combination therapies
• Bronchodilators
• Steroids
• Leukotriene antagonists
• PDE-4 inhibitors
• Other medications

PART 09: Segmentation by ROA
• Inhalation
• Oral

PART 10: Drug delivery devices market for COPD drugs
• Market overview
• Market segmentation by product type

PART 11: Geographical segmentation
• Global COPD drugs market by geography 2015-2020
• COPD drugs market in Americas
• COPD drugs market in EMEA
• COPD drugs market in APAC
• COPD drugs market in China

PART 12: Market drivers
• Increase in smoking prevalence
• Uptake of LABA/LAMA combination therapies
• Robust pipeline with tentative approval of drugs

PART 13: Impact of drivers

PART 14: Market challenges
• Lack of innovation in pipeline molecules
• Negligence toward use of controller medications
• Low diagnosis rates

PART 15: Impact of drivers and challenges

PART 16: Market trends
• Innovative technologies for drug delivery
• Increased adoption of e-cigarettes and smoking cessation products
• Emergence of ultrasonic nebulizers
• Increase in online marketing services
• Growing use of home healthcare devices

PART 17: Vendor landscape
• Competitive scenario
• Key news

PART 18: Key vendor analysis
• AstraZeneca
• Boehringer Ingelheim
• GSK
• Novartis
• Teva Pharmaceuticals
• Other prominent vendors

PART 19: Appendix
• List of abbreviations

PART 20: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Breakthrough research activities in field of COPD
Exhibit 03: Percentage share of pipeline molecules based on stage of development
Exhibit 04: Pipeline molecules based on MOA and stage of development
Exhibit 05: Percentage share of pipeline drugs based on MOA
Exhibit 06: Global COPD drugs market 2015-2020 ($ billions)
Exhibit 07: Global COPD drugs market snapshot: Developed and emerging markets 2015
Exhibit 08: Global COPD drugs market: Key parameters driving the market 2015
Exhibit 09: Five forces analysis
Exhibit 10: Key buying criteria for COPD drugs
Exhibit 11: Impact of key customer segments on global COPD drugs market
Exhibit 12: Segmentation of COPD drugs based on drug class
Exhibit 13: Percentage share of global COPD drugs by drug class based on revenue 2015
Exhibit 14: Global COPD drugs market: Drug class segmentation growth cycle analysis 2015
Exhibit 15: Combination therapies market in global COPD drugs market 2015-2020 ($ billions)
Exhibit 16: Bronchodilators market in global COPD drugs market 2015-2020 ($ billions)
Exhibit 17: Steroid drugs market in global COPD drugs market 2015-2020 ($ billions)
Exhibit 18: Leukotriene antagonists market in global COPD drugs market 2015-2020 ($ billions)
Exhibit 19: YoY growth and revenue of Daliresp 2012-2015 ($ billions)
Exhibit 20: Global COPD drugs market segmentation by drug class 2015
Exhibit 21: Segmentation of global COPD drugs market by ROA
Exhibit 22: Global COPD drug delivery devices market 2015-2020 ($ millions)
Exhibit 23: Global COPD devices market segmentation by product type
Exhibit 24: Percentage share of global COPD drug delivery devices by type 2015
Exhibit 25: Percentage share of inhalers in global COPD drug delivery devices market 2015
Exhibit 26: Inhalers market in global COPD drug-devices market 2015-2020 ($ millions)
Exhibit 27: Percentage share of nebulizers in global COPD drug delivery devices market by technology 2015
Exhibit 28: Nebulizers market in global COPD drug-devices market 2015-2020 ($ millions)
Exhibit 29: Global COPD drugs market by geography 2015-2020
Exhibit 30: Percentage share of global COPD drugs market by geography 2015 and 2020
Exhibit 31: Global COPD drugs market segmentation by geography 2015-2020 ($ billions)
Exhibit 32: Global share of COPD drugs market by geography 2015
Exhibit 33: COPD drugs market in Americas 2015-2020 ($ billions)
Exhibit 34: Prevalence rates of COPD in few coun
.....


【日本語目次(※自動翻訳出力)】

※以下は、Microsoft社の翻訳システムを使用した自動翻訳結果です。レイアウト崩れと不自然な日本語表現が多く表示されます。

。。。(後略)

【レポート販売概要】

■ タイトル:慢性閉塞性肺疾患(COPD)治療薬の世界市場2016-2020
■ 英文:Global Chronic Obstructive Pulmonary Disease Drugs Market 2016-2020
■ 発行日:2016年7月20日
■ 調査会社:Technavio
■ 商品コード:IRTNTR9968
■ 調査対象地域:グローバル

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼
慢性閉塞性肺疾患(COPD)治療薬の世界市場2016-2020 (Global Chronic Obstructive Pulmonary Disease Drugs Market 2016-2020 / IRTNTR9968)

※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。